Who
Keith Anthony Jones
Director
Company insider
Files Form 4 as: Director, Humacyte.
In numbers
- Trades disclosed
- 10
- Buys
- 3
- Sells
- 0
- Bought
- $61K
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 13 Jun 2024
- Last trade
- 14 Sep 2026
- Last filed
- 15 Sep 2026
Companies traded
Activity over time
1 Aug – 1 Oct
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 14 Sep 2026filed 15 Sep 2026 | HUMA HumacyteBiotechnology | SEC FORM 4 Bought | $5,62010,000 at $0.562 | filing |
| 14 Sep 2026filed 15 Sep 2026 | HUMA HumacyteBiotechnology | SEC FORM 4 Bought | $5,60010,000 at $0.56 | filing |
| 20 Aug 2026filed 21 Aug 2026 | HUMA HumacyteBiotechnology | SEC FORM 4 Bought | $6,93010,000 at $0.693 | filing |
| 20 Aug 2026filed 21 Aug 2026 | HUMA HumacyteBiotechnology | SEC FORM 4 Bought | $6,90010,000 at $0.69 | filing |
| 17 Aug 2026filed 19 Aug 2026 | HUMA HumacyteBiotechnology | SEC FORM 4 Bought | $18K30,000 at $0.594 | filing |
| 17 Aug 2026filed 19 Aug 2026 | HUMA HumacyteBiotechnology | SEC FORM 4 Bought | $18K30,000 at $0.59 | filing |
| 11 Jun 2026filed 12 Jun 2026 | HUMA Humacyteoption or derivative · Biotechnology | SEC FORM 4 Code A | —80,000 at $0.00 | filing |
| 11 Jun 2026filed 12 Jun 2026 | HUMA Humacyteoption or derivative · Biotechnology | SEC FORM 4 Code A | —80,000 at $0.00 | filing |
| 12 Jun 2025filed 16 Jun 2025 | HUMA Humacyteoption or derivative · Biotechnology | SEC FORM 4 Code A | —80,000 at $0.00 | filing |
| 13 Jun 2024filed 17 Jun 2024 | HUMA Humacyteoption or derivative · Biotechnology | SEC FORM 4 Code A | —75,000 at $0.00 | filing |
News
Humacyte at ASN Kidney Week: Phase 3 Trial Built for Women Shows ATEV Advantage Over Fistula, Getting Patients Off Catheters Months SoonerHUMA · manilatimes.net · 23 Oct 2026Humacyte Provides Commercial Update and Highlights Rapid Acceleration of Symvess Adoption by HospitalsHUMA · manilatimes.net · 15 Oct 2026
0 headlines in the last 90 days name Keith Anthony Jones; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.